News | July 28, 2008

Targeting Specific Tumor Regions Alters Treatment Plans

July 29, 2008 - Not all parts of a tumor respond to radiation therapy in the same way.

Treatments in the future may target the most resistant tumor regions, but measuring this resistance is far from straightforward, a new analysis shows.

Common radiation therapy prescribes a uniform radiation dose to the entire tumor, even though it is commonly known that some regions resist radiation more than others. Researchers are therefore experimenting with ways to tailor the treatment, with so-called "dose painting," so that more radiation falls on the radio-resistant parts.

For this to be effective, radio-resistance must be well-defined at the molecular level. This presumably can be done with PET scans using the radio-tracer FLT (fluoro-L-thymidine). When injected into the body, FLT is grabbed up by cells in the process of cell division. Therefore, rapidly-dividing cancer cells will look bright in a PET scan. Once treatment is started, those cells that remain bright would be considered radio-resistant (i.e. the radiation is not affecting their activity.) But this simple brightness measure, called a standardized uptake value (SUV), is not the only way to locate non-responsive cells in a PET image. A more precise way (based on a parameter called KFLT) is to model how the radio-tracer travels through the body and is taken up by cells over time.

Urban Simoncic of the Institut Jozef Stefan in Ljubljana, Slovenia, together with collaborators from University of Wisconsin-Madison compared the SUV and KFLT techniques on the exact same sets of PET scans and found that the two selected out different regions as being radio-resistant. This implies that a dose painting treatment based on one model would differ significantly from that based on the other. The researchers believe the community needs to address this discrepancy with more careful clinical investigation.

For more information: www.aapm.org

Source: American Association of Physicists in Medicine

Related Content

California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Philips Unveils IntelliSpace Radiation Oncology at ESTRO 2019
News | Oncology Information Management Systems (OIMS) | April 25, 2019
Philips announced IntelliSpace Radiation Oncology, an intelligent patient management solution to manage complexity,...
Accuray Launches Synchrony Motion Tracking and Correction Technology for Radixact System
Technology | Image Guided Radiation Therapy (IGRT) | April 24, 2019
Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact...
New Study Redefines Therapeutic Dose Guidelines for Non-Small Cell Lung Cancer
News | Lung Cancer | April 23, 2019
Non-small cell lung cancer is a common cancer for both men and women. Many people who are diagnosed with this type of...
Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index

Fig. 1: Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index. (Agarwal et al, Red Journal, 2019) Credit: Elsevier

News | Radiation Therapy | April 22, 2019
April 22, 2019 — A new study finds wide state
Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...